Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
KLOW is a laboratory research blend, and every figure below is provided so researchers can understand and reproduce the reported handling not as guidance for human use
Dependency risk
Supplied for in-vitro and laboratory research use only
Bollag RJ, Zhong Q, Ding KH, Phillips P, Zhong L, Qin F, Cranford J, Mulloy AL, Cameron R, Isales CM
April 8 Product: Supernus Pharmaceuticals SPN-830 Indication: Parkinsons disease Supernus Pharmaceuticals failed, for the second time, to secure approval for its drug-device combo SPN-830, which is intended for the continuous treatment of motor fluctuations in Parkinsons disease
US$ 27.59
US$ 28.80
US$ 24.21
US$ 24.09
US$ 27.48
US$ 21.41
US$ 28.74
US$ 28.92
